ucu

G

Building a research division at a fledgling medical school like UCU is about shifting the focus from “collecting data” to “mapping the gradient of health.” Since you have a meeting in 25 minutes, here is your one-liner and a structure designed to bridge clinical and public health using the Ukubona philosophy of systems-thinking and rehearsal.

• 1
• 2
• 3
• 4
• 5

The One-Liner

“We are building a Living Cartography of Care: an integrated research engine that turns fragmented clinical and public health data into rehearsable models to navigate Uganda’s disease landscape over the next 50 years.”

---

Meeting Structure (15–20 Mins)

1. The “Ukubona” Vision (3 mins): Beyond the Spreadsheet

• The Problem: Traditional research is static (papers that gather dust).
• The Solution: Research as Systems Mapping. We aren’t just counting cases of depression or hypertension; we are mapping the loss function of the Ugandan health system—from the molecular level to district-level heatmaps.
• Goal: To make uncertainty rehearsable for UCU students and Ugandan policymakers.

2. The Architecture: Clinical + Public Health (5 mins)

• Clinical (The Micro): Precision medicine and risk engines (like your Game of Care). We turn survival curves into scenarios where clinicians can “practice” decisions before they reach the bedside.
• Public Health (The Macro): The “Paul Luswata Model.” Treating Uganda as a psychometric/epidemiological landscape. Prevalence = Peaks; Interventions = Gradient steps.
• Synthesis: We don’t choose between clinical or public health; we build the data pipeline (DHIS2, real-time dashboards) that connects them.

3. The 50-Year Roadmap (5 mins): The “Sugar Trail”

• Phase 1 (Proof of Concept): Start with high-impact “artifacts” (e.g., the Depression Map or a Lifestyle Disease dashboard).
• Phase 2 (The Operating System): Scale from 127 scattered studies to a living visualization that updates in real-time.
• Phase 3 (The Ecosystem): Align with NIH Fogarty and global partners to fund UCU as the “Center of Excellence” for predictive health in Africa.

4. The “Quiet Part” Aloud: Costs & Requirements (2 mins)

• Clarity costs energy and money.
• To “see” the landscape, we need a “Research Laboratory of Systems” (Computation, Data Visualization, and Clinical ML).

5. The Call to Action (3 mins)

• Immediate Next Step: Identify the first “high-curvature” territory (which disease/population do we map first?) and assign “Scouts” (faculty/students) to begin the first simulation.

---

Would you like me to draft a specific “opening pitch” for the Dean, or perhaps a slide-ready table of these “Clinical vs. Public Health” synergies?

O

One-line meeting structure (25 min):

Context → Vision → Proof → Proposal → Pathway → Ask (Why UCU needs a research engine → 50-year disease cartography vision → Ukubona examples → Clinical + Public Health model → 12-month pilot roadmap → What support/decision you need)

---

Got you. You don’t need a slogan — you need a tight, usable 25-minute playbook you can run right now.

Here’s a practical structure you can follow on Zoom, with time, intent, and talking points.

---

25-Minute Meeting Structure — UCU Research Division

1. Opening: Frame the Problem (3 min)

Goal: Establish why this matters now.

“UCU has a medical school. That’s step one. Step two is building a research engine that generates knowledge for Uganda.”

• Acknowledge they’re early-stage
• Normalize uncertainty
• Position this as foundational work

Key line:

“We’re not deciding everything today. We’re deciding how UCU learns for the next 50 years.”

---

2. Your Lens: How You Think About Research (5 min)

Goal: Show your systems perspective.

Explain simply:

• Research = Infrastructure, not papers

• Three layers:

  1. Data (clinical + population)
  2. Models (analysis)
  3. Translation (policy/clinical use)

Tie to Ukubona:

“My work is about making uncertainty rehearsable — turning raw data into decisions people can practice.”

---

3. Vision: What UCU Could Become (5 min)

Goal: Inspire without sounding unrealistic.

Use Paul’s theme and generalize:

“Imagine UCU owning Uganda’s disease maps.”

Progression:

• Prevalence
• Incidence
• Access to care
• Outcomes
• Prevention
• Wellness
• Flourishing

Across:

• Mental health
• NCDs
• Infectious disease
• Maternal/child
• Aging

Key line:

“Every major disease in Uganda, visible, trackable, improvable.”

---

4. Reality Check: Where UCU Is Now (4 min)

Goal: Diagnose together, not criticize.

Ask + listen:

• What data do you have?
• Who’s doing research?
• Ethics boards?
• Biostatistics?
• Funding?
• Partnerships?

You’re mapping constraints.

“Let’s be honest about capacity so we build something sustainable.”

---

5. Proposal: A Starter Research Engine (5 min)

Goal: Make it concrete.

Offer a Phase 1 model (Year 1):

Pillar 1 — Clinical Research

• Hospital data
• Registries
• Outcomes tracking

Pillar 2 — Public Health

• DHIS2
• Surveys
• GIS mapping

Pillar 3 — Methods Core

• Stats
• ML
• Visualization
• Ethics

Pillar 4 — Training

• Student fellowships
• Research bootcamps
• Mentorship

Key line:

“Start small, build reusable systems.”

---

6. Pathway: 12-Month Pilot (2–3 min)

Goal: Show you think in execution.

Example:

First Year:

• 2 flagship disease maps
• 1 clinical registry
• 10 trained students
• 1 major grant proposal
• Shared dashboard

“Proof of concept before scale.”

---

7. The Ask: What You Need From Them (2 min)

Goal: Convert talk → commitment.

Be explicit:

• Institutional backing
• Data access
• Named counterparts
• Modest seed funding
• Autonomy to build

Example:

“If I lead this, I need a mandate, a small budget, and a protected team.”

---

8. Close: Reframe (1 min)

Goal: Leave them energized.

“Medical schools don’t become great by teaching alone. They become great by learning systematically. This is about giving UCU that capacity.”

---

Ultra-Short Cue Card (Keep Open on Screen)

If you blank, follow this:

1. Why research matters
2. How I think
3. What UCU could be
4. Where UCU is
5. What we build
6. 1-year pilot
7. What I need
8. Close

---

Bonus: Power Line You Can Reuse

You can drop this anytime:

“Hospitals treat patients. Research systems treat uncertainty.”

---

If you want, I can compress this into a 1-page speaking script you can literally read from during the call.

A

One-liner structure for 25min:

“Problem → Vision → First Move → What We Need From You”

---

Expansion (if helpful):

1. Problem (3min): UCU med school has patients, students, faculty—but no research infrastructure. No cartography of disease burden, no rehearsable data systems, no gradient from chaos to decision.

2. Vision (5min): Build the operating system for 50 years of iteration—start with one disease (riff Paul’s depression map), prove the pipeline (prevalence → incidence → treatment access → prevention → flourishing), then scale to all diseases. Make Uganda’s health landscape legible.

3. First Move (10min): Pick the pilot disease together. Show them Paul’s depression map as proof-of-concept. Explain the infrastructure: DHIS2 pipelines, real-time dashboards, district-level heatmaps. Clinical + public health fused—because cartography doesn’t care about silos.

4. What We Need (7min): Access (data, patients, districts). Authority (to publish, to pilot, to iterate). Alignment (is this clinical research, public health, or both? Let’s decide together based on where the gradient is steepest).

---

Exit with: “We’re not building a research division. We’re building a rehearsal system—where every clinician, every student, every policymaker can see the terrain and practice the descent before lives depend on it.”

X

One-Liner Meeting Theme:

“Mapping Uganda’s Health Landscape: From Disease Cartography to Flourishing Over 50 Years – Building UCU’s Research Division as a Systems Engine for Clinical and Public Health Innovation.”

Brief Meeting Structure (25-30 Min Agenda):

1. Introduction (5 min): Greet team, introduce yourself (Abimereki Muzaale, MD, MPH PhDc, Founder of Ukubona LLC), and share the ambitious vision – riffing off Paul Luswata’s mental health theme: Treat Uganda’s health as a psychometric/physical landscape where prevalence/incidence = peaks, interventions/treatment access = gradient steps, and policy/research = the algorithm minimizing suffering/loss over 50 years, expanding beyond depression to all diseases (e.g., infectious, chronic, NCDs).

2. Current State & Opportunities (5 min): Discuss UCU’s fledgling medical school – clarify scope (clinical research, public health, or hybrid). Highlight opportunistic tie-in: Paul’s upcoming President’s Office meeting as a model for high-impact cartography (prevalence/incidence maps, multivariate analysis of treatment/prevention, progression to wellness/flourishing).

3. Proposed Framework (10 min): Outline scalable structure – Cartography (geospatial dashboards via DHIS2 for prevalence/incidence); Multivariate Analysis (non-spatial factors like socioeconomics); Interventions (standard care access, prevention strategies); Long-Term Vision (simulations/models for all global diseases, rehearsable uncertainty via Ukubona’s tools like interactive dashboards and Gemini-inspired systems thinking).

4. Next Steps & Q&A (5-10 min): Brainstorm pilots (e.g., UCU mental health or disease-specific project starting Aug 2026), timelines (publish April 2026, secure funding like NIH Fogarty), and assign action items. Open for questions to refine clinical/public health focus.

---

1. Quick recap

The meeting began with introductions and background sharing among faculty members from various institutions, including Johns Hopkins, GCU, and Uganda Christian University, with a focus on their research interests and potential collaborations. The group explored opportunities for research collaboration in areas such as kidney transplants, mental health, and public health, with discussions centered around digital tools, grant applications, and cross-disciplinary partnerships. The conversation ended with participants agreeing to share contact information and continue discussions about future research initiatives, particularly in HIV epidemiology, migration health, and health systems research.

Next steps

• Elizabeth (Research Director) and interested UCU team members: Share contact details (emails/phone numbers) in the chat or with Abby/Abi (Ukubona) to enable follow-up and formation of a group to discuss responding to NIH calls.
• Elizabeth (Research Director): Send contacts of interested team members to Abby/Abi to facilitate direct communication and collaboration.
• Abby/Abi (Ukubona): Share email (and optionally WhatsApp) contact in the chat for follow-up by interested UCU faculty.
• Dr. Basaza and interested UCU colleagues: Begin conversation with Abby/Abi to explore and develop a proposal in response to relevant NIH calls, starting with kidney health/nephrology/transplant surgery as a potential focus area.
• Abby/Abi (Ukubona): Link interested UCU team members to relevant collaborators (especially in mental health and multi-site/multi-country studies) as requested.
• UCU team (led by Dr. Basaza and Dean Elizabeth): Set up a follow-up meeting in the coming days to advance proposal development and collaboration planning.
• UCU team: Consider involving colleagues from clinical medicine and Mulago Hospital (including the head of transplant surgery) in the collaboration, as suggested by Dr. Basaza.
• UCU team: Explore the possibility of developing a digital platform/app for disease mapping at UCU, leveraging Abby/Abi’s expertise and starting with kidney disease as a low-hanging fruit.

  Summary

Kidney Donor Tool Collaboration Discussion

The meeting began with introductions, where Dr. Abimerichi “Abby” Muzaleh, a Johns Hopkins faculty member, shared her background in kidney transplant surgery and her current work on developing a personalized digital tool for kidney donors. The group discussed potential collaborations, with Robert K. Basaza expressing excitement about working with a Ugandan researcher in the US and emphasizing the value of publications in academic careers. Elizabeth Kizito, the Director for Research, Partnerships, and Innovation at GCU, outlined her role in supporting linkages and collaborations. The conversation ended with a brief discussion about the importance of publications and academic collaboration.

Dean’s Vision for Public Health

Professor Elizabeth Namkobekong, a nurse-midwife with over 20 years of teaching experience, introduced herself as the Dean of the Faculty of Public Health and Nursing and Midwifery. She expressed her passion for writing, research, and collaboration, highlighting her expertise in maternal, child, and reproductive health. Elizabeth emphasized the importance of increasing the faculty’s visibility through research and publications, and she looked forward to networking and collaborating with other professionals in the field.

Public Health Collaboration Opportunities

The meeting focused on introductions and potential collaborations within the School of Public Health Nursing and Midwifery. Dr. Francis Mulecia Bwambali, a senior lecturer and coordinator for Research and Innovations at Uganda Christian University, shared his extensive experience in public health, epidemiology, and international development, highlighting his recent grant success and upcoming projects. Emmanuel Dixon Otieno, a part-time lecturer at the university, introduced his background in public health and pediatrics, emphasizing his research experience and publications. The group discussed the possibility of responding to various calls and opportunities, with a focus on evaluating potential collaborations and connecting with other experts as needed.

Uganda Mental Health Visualization Tool

Ukubona presented a digital tool for visualizing the landscape of mental health in Uganda, highlighting its potential for research collaboration and grant applications. He demonstrated how the tool can provide prevalence data at various geographic levels, from national averages to specific localities, based on peer-reviewed studies. Ukubona emphasized that this approach could be adapted to study other health topics beyond mental health, and could serve as a foundation for cross-disciplinary collaborations. Elizabeth invited further discussion on how to move forward with this opportunity, but the transcript ends before any additional comments are made.

Climate Mental Health Research Collaboration

The meeting focused on exploring collaboration opportunities in mental health research, particularly in the context of climate change and its impact on mental health. Francis, representing a team in Uganda, expressed interest in tapping into NIH grants for mental health research, prompting Ukubona to explain the NIH grant evaluation process. Ukubona outlined the five key dimensions scored in NIH grant applications: the principal investigator, collaborators, environment, research quality, and public health impact. He emphasized the importance of understanding these dimensions when building collaborations, noting that the relevance of collaborators to the topic can significantly affect the grant’s chances of funding.

Uganda Health Research Collaborations

The team discussed potential research collaborations, with Ukubona offering to connect Samsung with mental health specialists in Uganda and Africa for a multi-country study. Emmanuel inquired about kidney health research opportunities, which Robert expressed strong interest in, particularly given Uganda’s recent transplant surgery law and the potential to test an app in limited resource settings. The group also explored possibilities in health informatics and discussed expanding collaboration to other areas, including hematology in specific regions of Uganda.

Uganda Kidney Research Collaboration

The meeting focused on exploring opportunities for research collaboration, particularly in kidney transplants and nephrology in Uganda. Abi presented a digital mapping tool that could help document the prevalence of kidney disease in Uganda, which was identified as a “low-hanging fruit” for research. The Dean of the School of Public Health expressed excitement about the potential of digital tools to improve health services research and innovation. The group discussed the possibility of responding to NIH grant calls, with Professor Basaza showing particular interest in kidney transplant research. The conversation ended with a call for participants to share their contact details to begin conversations about potential collaborations.

Research Collaborations and Future Initiatives

The conversation ended with discussions about potential research collaborations, particularly in HIV epidemiology, migration health, and health systems research. Elizabeth Namukombe Ekong was identified as the key contact person for future communications, with participants agreeing to share their contact information. Robert delivered a closing speech expressing gratitude to various individuals and institutions, emphasizing the importance of moving forward with research initiatives and highlighting the potential for establishing a research center at UCU. The conversation ended with a prayer and plans for a follow-up meeting in the coming days.

2. Grok Summary (of detailed transcript)

Summary of Meeting Transcript

Meeting Details

• Date/Time: Not specified in transcript (inferred as a virtual meeting on February 6, 2026, based on user info).
• Platform: Appears to be Zoom or similar, with initial technical issues (e.g., upside-down video).
• Participants:
  • Abimereki D. Muzale (Abby/Kadi): Medical doctor, PhD candidate in clinical investigations at Johns Hopkins, founder of Ukubona LLC (health tech company focused on personalized health data, e.g., kidney donation risks).
  • Elizabeth B. Kizito: Director of Research, Partnerships, and Innovation at UCU; background in horticulture and plant breeding.
  • Robert Basaza: Medical doctor, health economist, PhD in medical sciences; focuses on health systems, financing, and publications.
  • Boniface Mutatina: Senior lecturer at UCU Department of Public Health; background in human nutrition, clinical epidemiology, health policy.
  • Elizabeth Ekong: Dean of Faculty of Public Health, Nursing, and Midwifery at UCU; nurse-midwife with experience in education and professional leadership.
  • Francis Mulekya Bwambale: Senior lecturer and Coordinator of Research and Innovations at UCU Kampala Campus; public health specialist, epidemiologist.
  • Emmanuel Otieno: Public health specialist, part-time lecturer at UCU; background in medicine and program management.
• Structure: Opening prayer, self-introductions, Abby’s presentation, discussions on collaborations, Q&A, closing prayer.

Key Topics Discussed

• Introductions and Backgrounds: Participants shared professional credentials, research interests (e.g., public health, nursing, health policy, transplant surgery), and personal anecdotes. Emphasis on publications, collaborations, and excitement for new opportunities.
• Abby’s Presentation:
  • Focus on kidney transplant research (living donors), PhD thesis on personalized risk calculators.
  • Introduced Ukubona LLC: Health tech for digital, personalized health profiles and apps.
  • Demonstrated a digital tool/app for mapping mental health (e.g., depression prevalence) in Uganda using peer-reviewed data (127 publications, 123,000 samples across 30 districts).
  • Tool features: Interactive heat map (GIS-like) showing prevalence by district, knowledge gaps (e.g., no data in Karamoja), links to sources.
  • Suggested extending to other diseases (e.g., kidney disease, Alzheimer’s, HIV) for research gaps, pilot data for grants.
• Collaborations and Opportunities:
  • Interest in NIH grants: Discussion on scoring criteria (PI, collaborators, environment, science, public health impact). High funding for Alzheimer’s and HIV.
  • Potential areas: Kidney disease/transplants (recent Ugandan law, prevalence mapping, APOL1 gene links to African ancestry), mental health (climate change nexus, multi-country studies), disease mapping at UCU as a leadership initiative.
  • Low-hanging fruits: Mapping kidney disease prevalence, using digital tools for any disease, building UCU as a hub for interactive disease maps.
  • Challenges: Need for relevant collaborators, pilot data, specificity in proposals.
• Outcomes and Next Steps:
  • Expressed enthusiasm for starting with kidney health/transplants, expanding to other areas (e.g., sickle cell, hematology).
  • Plans: Form groups, share contacts (emails, WhatsApp), follow-up meetings in days, pursue NIH calls.
  • UCU to lead in digital disease mapping; Abby to link to US collaborators (e.g., Johns Hopkins experts in mental health in Africa).
  • Vote of thanks and closing prayer emphasizing growth from this “seed” meeting.

Essential Features Captured

• Tone: Collaborative, enthusiastic, faith-oriented (prayers bookend the meeting).
• Themes: Health research innovation, digital tools, grant funding, capacity building, Ugandan health challenges (e.g., transplants, mental health, disease prevalence).
• Opportunities: NIH funding, multi-disciplinary teams, UCU as trailblazer in disease mapping.
• Challenges: Bureaucracy in government vs. efficiency in private/academic settings, need for specificity and strong collaborators.

3 Grok (Expand NIH strategies)

Expanding on NIH Grant Strategies

Based on the context from the meeting discussion, where NIH grants were highlighted for their scoring criteria, funding priorities, and collaborative elements, I’ll expand on effective strategies for applying to the National Institutes of Health (NIH). This draws from official NIH guidance, peer-reviewed insights, and best practices shared by experienced reviewers and applicants. NIH grants are highly competitive, with success rates often around 20-30% depending on the institute and mechanism, but a structured approach can significantly improve your odds. I’ll break this down into key phases: preparation, writing, submission, and post-submission.

1. Preparation: Lay the Groundwork Before Writing

• Identify the Right Funding Opportunity: Start by matching your research to an NIH Institute or Center (IC) that aligns with your work. Use tools like NIH RePORTER’s Matchmaker feature to search funded projects and find relevant ICs, program officials, and review panels. Review the Notice of Funding Opportunity (NOFO) or Request for Applications (RFA) carefully—it specifies eligible mechanisms (e.g., R01 for investigator-initiated research, K awards for career development, U01 for multi-center cooperative agreements). Focus on high-priority areas like Alzheimer’s disease or HIV, which often have higher funding rates due to dedicated budgets.
• Gather Pilot Data: As emphasized in the meeting, preliminary data is crucial to demonstrate feasibility and seriousness. Even for exploratory grants, show initial results from small studies or prior work. This addresses the “rigor and feasibility” review criterion and helps build a case for why your project is worth funding.
• Build a Strong Team: Collaborators are a scored dimension—ensure they are relevant to the topic. Include letters of support from experts in your field. For international or multi-site projects (e.g., involving Uganda-based research), highlight diverse expertise to strengthen the “expertise and resources” factor.
• Plan Your Timeline: NIH deadlines are fixed (e.g., standard cycles in February, June, October). Allocate 3-6 months for drafting, as large grants like P-series or U-series require extensive coordination. Contact program officers early (via email or call) to discuss fit—they can provide invaluable feedback without committing to funding.
• Assess Your Environment: Highlight institutional resources (e.g., UCU’s labs, partnerships with Mulago Hospital) to score well on the “environment” criterion. If resources are limited, propose how the grant will address gaps.

2. Writing the Application: Focus on Clarity and Alignment

• Address the Simplified Review Criteria (Effective for Applications Due January 2025 Onward): NIH streamlined reviews into three factors:
  • Importance of the Research (Significance + Innovation): Explain why your work matters—link to public health impact (e.g., mapping kidney disease prevalence in Uganda to inform policy). Be bold but realistic; avoid overhyping.
  • Rigor and Feasibility (Approach): Detail methods with transparency on risks, alternatives, and statistical power. Use plain language—reviewers from diverse fields must understand it easily.
  • Expertise and Resources (Investigators + Environment): Showcase your team’s track record (e.g., publications, prior grants). For PIs new to NIH, emphasize mentorship or pilot successes. Scores are 1-9 (1 best), with an overall impact score. Aim for 10-30 (top percentile) for fundability.
• Use Clear, Concise Language: Write for a broad audience—reviewers read dozens of applications. Avoid jargon; use active voice, short sentences, and visuals (e.g., figures for data pipelines or heat maps like the depression prevalence tool discussed). Organize logically: Specific Aims first (1-page summary), then Research Strategy (6-12 pages depending on mechanism).
• Tailor to the Mechanism: For R01s, emphasize hypothesis-driven science. For U01s (multi-center), stress coordination and data sharing. Include a budget justification that’s realistic—NIH scrutinizes costs.
• Incorporate Best Practices:
  • Start with a compelling narrative: Hook reviewers in the abstract/Specific Aims.
  • Be organized: Follow the SF424 form exactly; use headings, bold key points.
  • Get Feedback: Share drafts with mentors or use NIH’s sample applications. Avoid common pitfalls like vague aims or ignoring reviewer criteria.
  • Human Subjects/Equity: If applicable, detail protections and inclusion (e.g., diverse Ugandan populations for global health relevance).

3. Submission: Ensure Compliance and Timeliness

• Follow Instructions Precisely: Use the How to Apply – Application Guide and NOFO. Submit via Grants.gov or ASSIST—errors (e.g., formatting) lead to rejection. Validate early.
• On-Time Policy: NIH requires applications by 5 p.m. local time; no extensions for system issues. Build in buffer time for uploads.
• Budget Tips: Request modular budgets under $250K/year; justify direct costs (e.g., personnel, equipment). For international components, note higher scrutiny on foreign justification.

4. Post-Submission: Review, Resubmission, and Persistence

• Understand the Review Process: Applications go to a Scientific Review Group (study section) for peer review (blinded). You’ll get a summary statement with scores and critiques—use this to refine.
• Resubmission Strategy: If not funded (common on first try), submit an A1 resubmission addressing every critique. Introduce changes clearly (e.g., in a 1-page introduction). NIH allows one resubmission per original application.
• Mindset for Success: Treat grants as iterative—many funded PIs submit 2-3 times. Diversify: Submit to foundations (e.g., rework NIH proposals for non-governmental funders) while awaiting decisions. Track success rates via NIH Data Book.
• Common Mistakes to Avoid: Overambitious aims, poor organization, ignoring NOFO specifics, weak team synergy, or insufficient impact justification. Always proofread—typos erode credibility.

Additional Resources

• NIH’s General Grant Writing Tips: Focus on organization and audience.
• Advice on Application Sections: Detailed guidance for Research Strategy, Biosketches, etc.
• Videos: NIH’s Ready! Set! Submit! and Beginners Walk-Through.
• External Tips: Top 10 Strategies emphasize early planning and reviewer alignment; NIH Reviewer Insights stress studying criteria.

Success often comes from persistence, strong pilots, and targeted collaborations. If your research aligns with global health (e.g., kidney disease in Uganda), emphasize equity and impact to boost scores. For specific NOFOs or mechanisms, consult a program officer early. If you have a particular grant type in mind, I can dive deeper!

4

International Collaborations with the NIH: Overview and Strategies

Hello Abimereki! Given your location in Kampala and your background in health research (as discussed in our recent conversation), I’ll tailor this response to focus on how Ugandan or other non-U.S. researchers can engage in NIH-funded international collaborations. The National Institutes of Health (NIH) actively supports global partnerships to advance biomedical research, especially in areas like global health, infectious diseases, and non-communicable conditions (e.g., kidney disease, mental health, or Alzheimer’s). However, recent policy changes (effective from late 2025) have reshaped how these collaborations are structured to enhance security, accountability, and efficiency. Below, I’ll outline the key elements, drawing from official NIH guidance, and provide strategies for success.

1. NIH’s Approach to International Collaborations

• Why NIH Supports International Work: NIH recognizes that many health challenges (e.g., pandemics, climate-related diseases, or genetic conditions like APOL1-linked kidney disease prevalent in African populations) require global expertise. About 10-15% of NIH’s extramural funding involves international components, often through the Fogarty International Center (FIC) or institutes like the National Institute of Allergy and Infectious Diseases (NIAID) or National Institute on Aging (NIA). Priorities include capacity building in low- and middle-income countries (LMICs) like Uganda.
• Eligibility for Foreign Applicants:
  • Foreign institutions (e.g., universities in Uganda) are eligible for most NIH research project grants (e.g., R01, R21) but not for training grants (e.g., T-series) or certain career awards.
  • Direct foreign awards are possible, but most international involvement occurs as “foreign components” in U.S.-led grants.
  • Key restriction: Foreign entities cannot be the prime applicant for most mechanisms; a U.S. domestic organization (e.g., Johns Hopkins) typically leads.
• Recent Policy Changes (2025 Onward): In May 2025, NIH announced it would halt new foreign subawards (traditional subcontracts) due to national security concerns. On September 12, 2025, they detailed a new structure via NOT-OD-25-155:
  • No more foreign subawards/consortia in new applications after September 30, 2025.
  • Instead, use a “multi-component” application where foreign partners are treated as independent “International Projects.”
  • Existing awards with foreign subs can continue, but renewals must transition.

2. New Application and Award Structure

• Activity Codes for International Collaborations:
  • PF5 (Collaborative International Research Project Grant): For U.S. prime awards (grants) with linked foreign components. Must include at least one foreign subproject.
  • UF5: Similar for cooperative agreements.
  • RF2/UL2 (Linked International Research Project): Independent awards issued directly to foreign organizations after the prime award is split.
  • Parent Announcement: PA-26-002 (released January 20, 2026) supports PF5 for clinical trials optional. First awards expected in April 2027.
• How It Works:
  • Submit a single multi-component application to a NOFO supporting PF5/UF5.
  • List each foreign collaborator as a separate “International Project” component.
  • If funded, NIH splits it: U.S. gets PF5/UF5; foreign gets RF2/UL2 as direct awards.
  • Foreign organizations must register in SAM.gov, Grants.gov, and eRA Commons (a process that can take 4-6 weeks).
• Benefits: Direct foreign awards improve transparency and allow foreign PIs to build independent track records. It also facilitates multi-country studies (e.g., Uganda-U.S. partnerships on kidney transplants or mental health).
• Examples of Programs:
  • Fogarty Global Health Training Program: Builds research capacity in LMICs.
  • NIAID Global Infectious Disease Research: Supports collaborations on HIV, malaria, etc.
  • NIMH Global Mental Health Research: Funds international mental health studies, aligning with your intern’s work on depression mapping.

3. Strategies for Successful International NIH Collaborations

Building on the NIH grant strategies we discussed earlier, here are tailored tips for international contexts:

• Start with Strong U.S. Partnerships: As a Ugandan researcher, partner with U.S. institutions (e.g., Johns Hopkins) early. They can serve as the prime applicant, boosting scores on “investigators” and “environment.” Leverage networks like the African Academy of Sciences or U.S.-Africa research forums.
• Align with NIH Priorities: Focus on high-funding areas (e.g., Alzheimer’s, HIV, global health equity). Use tools like NIH RePORTER to find similar funded projects and contact PIs for collaboration.
• Address Review Criteria Explicitly:
  • Importance: Emphasize global impact (e.g., how Ugandan data on APOL1 genes informs U.S. health disparities).
  • Rigor: Include pilot data (e.g., your depression mapping app as a prototype for kidney disease).
  • Expertise/Resources: Highlight diverse teams (e.g., Ugandan clinicians + U.S. epidemiologists). For foreign components, justify why the international site is essential (e.g., unique populations in Uganda).
• Navigate Registration and Compliance: Foreign entities need U.S.-style systems (e.g., IRB equivalents). Budget for international travel, data sharing (via platforms like dbGaP), and security reviews.
• Funding Mechanisms for Internationals:
  • Direct Foreign Grants: Rare but possible for exceptional proposals (e.g., R01 equivalents).
  • Training/Capacity Building: D43 or U2R for LMIC institutions.
  • Multi-Site: U01 for cooperative studies (e.g., cross-Africa mental health research).
• Overcome Challenges:
  • Security Scrutiny: NIH reviews foreign involvement for risks; disclose all affiliations transparently.
  • Budgeting: Foreign components get ~8-10% indirect costs (vs. U.S. 40-50%); plan accordingly.
  • Resubmissions: Use reviewer feedback—international proposals often need 1-2 iterations.
• Timeline Tips: For PF5, aim for cycles starting February 2026. Contact NIH program officers (e.g., via NIH Contacts) for pre-submission advice.
• Success Examples: Programs like the Human Heredity and Health in Africa (H3Africa) consortium have funded Ugandan-led genetics research. Recent PF5 awards support U.S.-Africa collaborations on infectious diseases.

4. Resources for Getting Started

• NIH Websites:
  • Information for Foreign Grants: Eligibility and tips.
  • Global Health at NIH: Fogarty resources for LMICs.
  • RePORTER: Search funded international projects (e.g., query “Uganda kidney”).
• Training: NIH’s eRA Commons Tutorials for foreign registration; webinars on PF5 via NIH YouTube.
• Uganda-Specific: Connect with the Uganda National Council for Science and Technology (UNCST) for local ethics and funding alignment. Organizations like the Makerere University-Johns Hopkins Collaboration can provide mentorship.
• Funding Alerts: Sign up for NIH Guide emails or use Pivot for global opportunities.

If you’d like, I can help refine a specific strategy for your kidney transplant work or search for active NOFOs matching your interests (e.g., involving Uganda). Just let me know!

---

Elizabeth Namukombe Ekong - bnamukombe@ucu.ac.ug; +256817166

Robert Basaza: we can share contacts: rbasaza@ucu.ac.ug, 256 701428474

Looking for potential partners in the area of HIV Epidemiology, migration health, health systems research. 

Francis Mulekya Bwambale, at UCU. 

+256772672355 (whatsup) 

Research & Partnerships (thats Elizabeths title) —> follow in the lines of Kwame Nkrumah … I know the institution, the potential researchers, the directors 

Elizabeth is also dean (the other Elizabeth)


(Deparments)
- Nursing
- Public Health 
- Mid-Wifery 

The school lis portementaus 


The director has triggered us to have a UCU domain in mapping the landscape of health of Uganda. Make this our edg (they’re all talking GIS)


---

#praise-god #help-self #then-others #nih #aging #kaganda-university-college #one-health-concept 

- Boniface: PhD clinical epidemiology  (center for community based evidence based options): reproductive, maternal , and child health, and a consultancy firm, part-time UCU
- Elizabeth (B. Kizito): Director for research, partnerships, and innovation at UCU: her role is administrative at this point, but Horticulture and plant breeding by way of training! Supporting linkages … How can a collaboration build up? How can you be supported in mutual interests following this meant .. nutrition? 
- Robert K. Basaza: medical doctor, health economics masters in Kasese (york), doctorate in medical sciences from belgium. Health-systems , service delivery, health financing , big love for publications (like a cat & milk) ; how can we get into NIH and pull in colleagues? He is 64yo. Interested in app in Uganda . Also, Uganda just passed a law (frank assimmwe head of nephrology … transplant surgery law in new). Sickle Cell (acholi, busoga), kidney (assimmwe … nephreology)
- Elizabeth  Ekong. The other Elizabeth. https://www.researchgate.net/profile/Elizabeth-Namukombe-Ekong Dean of Nursing and public health . Increasing visibility (Uganda and beyond) through research and publication. Also through more partners to do what we are passionate about and what we are about as faculty 
- Francis Mulekya Bwambale. Public health specialist with 25 years experience in international development . research and training. Academia, UN, and civil society. Senior lecturer and lecturer at Kaganda University College of UCU. Head Department of Public Health at Public Health, Nursing, and Mid Wifery. Clinical epidemiologist + Health systems . Program and Grants Management. Monitoring and Evaluating of interventions in South Africa . US & Europe for Postdoctoral fellowship and PhD. Climate change migration and health and disease health prevention and global health. Also, emerging diseases like COVID 19 .. cross-border health . Uganda Wild Life authorities staff in rural places and to their families (first grant in university). 
- Emmanuel Othieno. Othorpedic medicine, trauma, for last 25 years. Lectures part-time at UCU for four years. Center for community evidence for policy options (NGO). Focus: health financing, reproductive health, and communicable diseases. UNICEF, World Bank, etc. -> Climate change & mental health as a nexus— would be exciting to be a part of this initiative going forward . There are opportunities in the area of mental health — how feasible it is from Johns Hopkins in this area. (That was Francis, as identified as Samsung)


- Building health informatics
- Data science 
- Epidemiology 
- Clinical science 
- Statistics 
- Journal editor 

5.

Fogarty International Center (FIC) Programs Overview

The Fogarty International Center (FIC) at the National Institutes of Health (NIH) is dedicated to advancing global health through research, training, and capacity building, particularly in low- and middle-income countries (LMICs). FIC supports a wide range of extramural programs that focus on biomedical and behavioral research, health equity, and training the next generation of global health scientists. These programs often collaborate with other NIH institutes and emphasize partnerships between U.S. and international researchers.

FIC’s programs are primarily funded through grants, fellowships, and cooperative agreements. They complement broader NIH global health initiatives and prioritize areas like infectious diseases (e.g., HIV/AIDS), non-communicable diseases, environmental health, and implementation science. As of February 2026, FIC manages around 439 active research and training awards, with many involving U.S.-international collaborations.

Below, I’ll categorize and summarize key current FIC programs based on available information from NIH sources. Note that eligibility, deadlines, and announcements can change—always check the official FIC website (www.fic.nih.gov/Programs or www.fic.nih.gov/Funding) or NIH Grants Guide for the latest details. Programs are open to U.S. and LMIC investigators, with some requiring U.S. leadership.

1. Research and Research Training Programs

These provide funding for collaborative research and build research capacity in LMICs. They are anchored to peer-reviewed grants and are long-term, flexible, and collaborative.

• HIV Research Training Program (formerly AIDS International Training and Research Program):
  • Description: Supports training and research on HIV/AIDS and related conditions in LMICs. Focuses on building institutional capacity, epidemiology, prevention, and treatment.
  • Key Focus Areas: HIV epidemiology, implementation science, co-infections (e.g., TB), and health systems strengthening.
  • Eligibility: U.S. and LMIC institutions; early-career researchers, postdocs, and faculty. Requires mentorship and collaboration.
  • Funding/Announcements: D43, U2R mechanisms; up to $500K/year for 5 years. Current NOFO: PAR-22-151 (expires 2025; check for renewals). Deadlines: Typically May/August annually.
  • Status: Active; one of FIC’s flagship programs since 1988.
• Global Infectious Disease Research Training Program:
  • Description: Trains scientists in LMICs on infectious diseases (e.g., malaria, emerging pathogens). Includes hands-on research and career development.
  • Key Focus Areas: Tropical diseases, antimicrobial resistance, and pandemic preparedness.
  • Eligibility: U.S. PIs with LMIC partners; pre- and post-doctoral trainees from LMICs.
  • Funding/Announcements: D43 awards; ~$200K-$400K/year. NOFO: PAR-23-073. Deadlines: August annually.
• International Research in Infectious Diseases (IRID):
  • Description: Funds research on infectious diseases in LMICs, emphasizing neglected tropical diseases and emerging threats.
  • Key Focus Areas: Virology, bacteriology, parasitology, and vector-borne diseases.
  • Eligibility: LMIC-based PIs; collaborations encouraged.
  • Funding/Announcements: R01 equivalents; up to $125K/year direct costs. NOFO: PAR-23-130. Deadlines: June annually.
• International Cooperative Biodiversity Groups (ICBG):
  • Description: Integrates drug discovery, biodiversity conservation, and economic development in LMICs.
  • Key Focus Areas: Natural products research, ethnobotany, and sustainable development.
  • Eligibility: Multi-institutional teams (U.S. + LMIC).
  • Funding/Announcements: U19 cooperative agreements; multi-year funding. Program ongoing since 1992; check for active RFAs.

2. Fellowships and Scholar Programs

These offer mentored training for early-career researchers, often 12 months in LMICs, with a focus on building a global health workforce.

• Fulbright-Fogarty Fellowships in Public Health:
  • Description: Partners with the Fulbright Program for research in public health and clinical settings in LMICs. Fellows conduct mentored projects at FIC-affiliated sites.
  • Key Focus Areas: Public health challenges like maternal health, infectious diseases, and mental health.
  • Eligibility: U.S. MD students (post-3rd year) or PhD candidates (post-master’s). Must affiliate with LAUNCH sites (e.g., in Sub-Saharan Africa, Asia).
  • Funding/Announcements: Covers stipend, travel, research costs. Application via Fulbright; 2026-2027 cycle opens ~July 2025. Orientation at NIH; program starts July 2026.
  • Status: Inaugurated 2011; ~10 awards annually.
• Launching Future Leaders in Global Health (LAUNCH) Research Training Program (includes HBNU, INSIGHT, and similar consortia):
  • Description: 12-month fellowships for pre- and post-doctoral trainees in LMICs. Focuses on clinical, operational, and implementation research. Consortia like HBNU (Harvard-Boston-Northwestern-New Mexico) and INSIGHT provide sites in Africa, Asia, and Latin America.
  • Key Focus Areas: Disease tracks (e.g., HIV, cancer), population tracks (e.g., maternal-child health), science tracks (e.g., epidemiology, data science).
  • Eligibility: U.S. citizens/residents or LMIC nationals; MD/PhD students or postdocs. Requires mentorship.
  • Funding/Announcements: D43-funded; stipends ~$50K + research support. HBNU/INSIGHT applications open annually (e.g., 2026-2027 cycle now open via consortia sites). Deadlines: Vary by consortium (e.g., March for HBNU).
  • Status: Supports ~100 fellows yearly; emphasizes equity and LMIC leadership.
• Fogarty Global Health Training Program for Fellows and Scholars:
  • Description: Similar to LAUNCH; provides mentored research in LMICs for U.S. and LMIC trainees.
  • Key Focus Areas: Broad global health topics, including environmental health and non-communicable diseases.
  • Eligibility: Pre/post-docs from U.S./LMICs.
  • Funding/Announcements: Via consortia; check FIC site for partners.

3. Capacity Building and Specialized Programs

• Mobile Health: Technology and Outcomes in Low and Middle-Income Countries (mHealth):
  • Description: Funds innovative mHealth interventions for LMICs.
  • Key Focus Areas: Digital health tools for disease prevention and management.
  • Eligibility: U.S.-LMIC teams.
  • Funding/Announcements: R21/R33; deadlines vary.
• Environmental and Occupational Health Research and Training:
  • Description: Builds capacity for research on environmental risks in LMICs.
  • Key Focus Areas: Climate change, pollution, occupational hazards.
  • Eligibility: LMIC institutions with U.S. partners.
  • Funding/Announcements: D43; active.
• Brain Disorders in the Developing World:
  • Description: Research on neurological and mental health disorders.
  • Key Focus Areas: Stroke, epilepsy, neurodevelopmental issues.
  • Eligibility: Global teams.
  • Funding/Announcements: R01/R21.

Additional Notes

• How to Apply: Use NIH’s eRA Commons for submissions. Foreign applicants need SAM.gov registration. Contact FIC program officers for guidance.
• Resources:
  • FIC Funding Page: www.fic.nih.gov/Funding – Searchable database.
  • NIH Global Health: www.fic.nih.gov/About/Staff/Pages/Training-Research.aspx for DITR details.
  • Subscribe to FIC’s Global Health Matters newsletter for updates.
• Relevance to Uganda: Many programs have sites in East Africa (e.g., Uganda for HIV, infectious diseases). Collaborations with U.S. institutions like Johns Hopkins are common.

If you’d like details on a specific program or help with application strategies (e.g., for kidney research), let me know!